SKYSTAR BIO-PHARMACEUTICAL CO Interest Expense
SKYSTAR BIO-PHARMACEUTICAL CO reported Interest Expense of $154.79 thousand for the 3-month period ending 2013-09-30, per its 10-Q filed 2014-11-14.
Discontinued › Expense Statement › Interest Expense
us-gaap:InterestExpense · last filed 2014-11-14
- SKYSTAR BIO-PHARMACEUTICAL CO interest expense for the quarter ending 2013-09-30 was $154.79K, a 22.47% decline year-over-year.
- SKYSTAR BIO-PHARMACEUTICAL CO interest expense for the quarter ending 2013-06-30 was $221.07K.
- SKYSTAR BIO-PHARMACEUTICAL CO interest expense for the quarter ending 2012-12-31 was $255.83K.
- SKYSTAR BIO-PHARMACEUTICAL CO interest expense for the quarter ending 2012-09-30 was $199.66K, a 70.58% increase year-over-year.
- SKYSTAR BIO-PHARMACEUTICAL CO interest expense for fiscal 2012 was $764.50K.
| Period end | Interest Expense 3 month | Interest Expense 6 month | Interest Expense 9 month | Interest Expense 12 month |
|---|---|---|---|---|
| 2013-09-30 | $154.79K 10-Q · filed 2014-11-14 | $375.86K derived: sum of 2 quarters · filed 2014-11-14 | $565.25K 10-Q · filed 2014-11-14 | |
| 2013-06-30 | $221.07K 10-Q · filed 2014-08-14 | $410.46K 10-Q · filed 2014-08-14 | ||
| 2012-12-31 | $255.83K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-31 | $455.49K derived: sum of 2 quarters · filed 2014-03-31 | $764.50K 10-K · filed 2014-03-31 | |
| 2012-09-30 | $199.66K 10-Q · filed 2012-11-14 | $508.67K 10-Q · filed 2012-11-14 | ||
| 2011-09-30 | $117.05K 10-Q · filed 2012-11-14 | $266.80K 10-Q · filed 2012-11-14 |